Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wyles

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Lancet. Gastroenterology & Hepatology|January 13, 2022
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trialSunil S Solomon, Sandra Wagner-Cardoso, Laura Smeaton, et al.
Critical Care Explorations|October 26, 2022
Severe Acute Respiratory Infection-Preparedness: Protocol for a Multicenter Prospective Cohort Study of Viral Respiratory InfectionsRadu Postelnicu, Avantika Srivastava, Pavan K Bhatraju, et al.
JAMA|February 24, 2015
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trialMark S Sulkowski, Joseph J Eron, David Wyles, et al.
The New England Journal of Medicine|April 24, 2013
Sofosbuvir for previously untreated chronic hepatitis C infectionEric Lawitz, Alessandra Mangia, David Wyles, et al.
Critical Care Explorations|July 18, 2024
COVID-19 Across Pandemic Variant Periods: The Severe Acute Respiratory Infection-Preparedness (SARI-PREP) StudyVikramjit Mukherjee, Radu Postelnicu, Chelsie Parker, et al.
Critical Care Explorations|January 5, 2023
Angiopoietin-Like4 Is a Novel Marker of COVID-19 SeverityPavan K Bhatraju, Eric D Morrell, Ian B Stanaway, et al.
Critical Care Medicine|February 15, 2023
Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 PandemicGeorge L Anesi, Adair Andrews, He Julia Bai, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Lancet. Gastroenterology & Hepatology|January 13, 2022
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trialSunil S Solomon, Sandra Wagner-Cardoso, Laura Smeaton, et al.
Critical Care Explorations|October 26, 2022
Severe Acute Respiratory Infection-Preparedness: Protocol for a Multicenter Prospective Cohort Study of Viral Respiratory InfectionsRadu Postelnicu, Avantika Srivastava, Pavan K Bhatraju, et al.
JAMA|February 24, 2015
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trialMark S Sulkowski, Joseph J Eron, David Wyles, et al.
The New England Journal of Medicine|April 24, 2013
Sofosbuvir for previously untreated chronic hepatitis C infectionEric Lawitz, Alessandra Mangia, David Wyles, et al.
Critical Care Explorations|July 18, 2024
COVID-19 Across Pandemic Variant Periods: The Severe Acute Respiratory Infection-Preparedness (SARI-PREP) StudyVikramjit Mukherjee, Radu Postelnicu, Chelsie Parker, et al.
Critical Care Explorations|January 5, 2023
Angiopoietin-Like4 Is a Novel Marker of COVID-19 SeverityPavan K Bhatraju, Eric D Morrell, Ian B Stanaway, et al.
Critical Care Medicine|February 15, 2023
Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 PandemicGeorge L Anesi, Adair Andrews, He Julia Bai, et al.
Pageof 4